<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36199500</PMID><DateRevised><Year>2022</Year><Month>10</Month><Day>07</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1178-7090</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Journal of pain research</Title><ISOAbbreviation>J Pain Res</ISOAbbreviation></Journal><ArticleTitle>Patterns of Viral Arthropathy and Myalgia Following COVID-19: A Cross-Sectional National Survey.</ArticleTitle><Pagination><StartPage>3069</StartPage><EndPage>3077</EndPage><MedlinePgn>3069-3077</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2147/JPR.S373295</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">Viral arthropathy is an increasingly recognized sequela of several viral pathogens including alphaviruses, hepatitis, and potentially coronaviruses. Case reports of viral arthropathy and myalgia associated with SARS-CoV-2 infection (COVID-19) both during active disease and following resolution of acute COVID-19 symptoms are becoming more prevalent. We sought to describe the prevalence of viral arthropathy and myalgia associated with COVID-19, as well as to identify factors that may predict these symptoms.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A national, cross-sectional survey was conducted using a questionnaire administered online. Subjects self-reporting previous confirmed COVID-19 were recruited using the Amazon Mechanical Turk crowdsourcing platform. Questionnaire items included demographics, frequency and severity of common COVID-19 symptoms, requirement for hospitalization or mechanical ventilation, subject recall of arthropathy or myalgia onset, duration, and severity, as well as WOMAC score. Binary logistic regression was used to identify potential predictive co-variates for the development of either arthropathy or myalgia.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A total of 3222 participants completed the arthropathy/myalgia questionnaire with 1065 responses remaining for analysis following application of exclusion criteria, data integrity review, and omission of respondents with confounding conditions. Of the 1065 cases, 282 (26.5%) reported arthralgia and 566 (53.2%) reported myalgia at some point during or after COVID-19 with 9.9% and 6.0% reporting onset of arthralgia or myalgia, respectively, after resolution of acute COVID-19 symptoms. The presence of several commonly reported COVID symptoms or indicators of disease severity was predictive of arthralgia including hospitalization (OR 3.7; 95% CI 2.4 to 5.8), sore throat (OR 2.3; 95% CI 1.5 to 3.5), fatigue (OR 2.9; 95% CI 1.7 to 4.9), and ageusia/anosmia (OR 1.7; 95% CI 1.1 to 2.7).</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="UNASSIGNED">Based on these results, new-onset arthropathy and myalgia following COVID-19 resolution may be an increasingly encountered etiology for pain.</AbstractText><CopyrightInformation>&#xa9; 2022 Herndon and Nguyen.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Herndon</LastName><ForeName>Christopher M</ForeName><Initials>CM</Initials><Identifier Source="ORCID">0000-0003-2387-415X</Identifier><AffiliationInfo><Affiliation>School of Pharmacy, Southern Illinois University Edwardsville, Edwardsville, IL, 62026, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Van</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Hospital Sisters Health System, O'Fallon, IL, 62269, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>J Pain Res</MedlineTA><NlmUniqueID>101540514</NlmUniqueID><ISSNLinking>1178-7090</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">arthritis</Keyword><Keyword MajorTopicYN="N">joint pain</Keyword><Keyword MajorTopicYN="N">long-COVID</Keyword><Keyword MajorTopicYN="N">myalgia</Keyword><Keyword MajorTopicYN="N">viral arthropathy</Keyword></KeywordList><CoiStatement>Dr Van Nyugen certifies that she has no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers&#x2019; bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript. Dr Herndon has received financial support in the form of grants and contracts from the Illinois Department of Human Services and for consultant work for the United States Department of Justice. Additionally, Dr Herndon received intramural funding to support this study from the Department of Pharmacy Practice, School of Pharmacy, Southern Illinois University Edwardsville.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>6</Day><Hour>2</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>7</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>9</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36199500</ArticleId><ArticleId IdType="pmc">PMC9528961</ArticleId><ArticleId IdType="doi">10.2147/JPR.S373295</ArticleId><ArticleId IdType="pii">373295</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Suhrbier A, Mahalingam S. The immunobiology of viral arthritides. Pharmacol Ther. 2009;124(3):301&#x2013;308. doi:10.1016/j.pharmthera.2009.09.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2009.09.005</ArticleId><ArticleId IdType="pubmed">19788897</ArticleId></ArticleIdList></Reference><Reference><Citation>Marks M, Marks JL. Viral arthritis. Clin Med. 2016;16(2):129&#x2013;134. doi:10.7861/clinmedicine.16-2-129</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmedicine.16-2-129</ArticleId><ArticleId IdType="pmc">PMC4868140</ArticleId><ArticleId IdType="pubmed">27037381</ArticleId></ArticleIdList></Reference><Reference><Citation>Vassilopoulos D, Calabrese LH. Virally associated arthritis 2008: clinical, epidemiologic, and pathophysiologic considerations. Arthritis Res Ther. 2008;10(5):215. doi:10.1186/ar2480</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/ar2480</ArticleId><ArticleId IdType="pmc">PMC2592818</ArticleId><ArticleId IdType="pubmed">18828883</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerr J, Macartney K, Britton PN. Influenza-associated myositis: a single-centre, 5-year retrospective study. Eur J Pediatr. 2021;180(2):577&#x2013;584. doi:10.1007/S00431-020-03835-W</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S00431-020-03835-W</ArticleId><ArticleId IdType="pubmed">33095429</ArticleId></ArticleIdList></Reference><Reference><Citation>Saud A, Naveen R, Aggarwal R, Gupta L. COVID-19 and myositis: what we know so far. Curr Rheumatol Rep. 2021;23(8). doi:10.1007/S11926-021-01023-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S11926-021-01023-9</ArticleId><ArticleId IdType="pmc">PMC8254439</ArticleId><ArticleId IdType="pubmed">34216297</ArticleId></ArticleIdList></Reference><Reference><Citation>Nauss MD, Schmidt EL, Pancioli AM. Viral myositis leading to rhabdomyolysis: a case report and literature review. Am J Emerg Med. 2009;27(3):372.e5&#x2013;372.e6. doi:10.1016/J.AJEM.2008.07.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.AJEM.2008.07.022</ArticleId><ArticleId IdType="pubmed">19328397</ArticleId></ArticleIdList></Reference><Reference><Citation>de Wit E, van Doremalen N, Falzarano D, Munster VJ. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol. 2016;14:523&#x2013;534. doi:10.1038/nrmicro.2016.81</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro.2016.81</ArticleId><ArticleId IdType="pmc">PMC7097822</ArticleId><ArticleId IdType="pubmed">27344959</ArticleId></ArticleIdList></Reference><Reference><Citation>Bekaryssova D, Yessirkepov M, Zimba O, Gasparyan AY, Ahmed S. Reactive arthritis before and after the onset of the COVID-19 pandemic. Clin Rheumatol. 2022;41(6):1641&#x2013;1652. doi:10.1007/S10067-022-06120-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S10067-022-06120-3</ArticleId><ArticleId IdType="pmc">PMC8898028</ArticleId><ArticleId IdType="pubmed">35247132</ArticleId></ArticleIdList></Reference><Reference><Citation>Fragata I, Mour&#xe3;o AF. Coronavirus disease 19 (COVID-19) complicated with post-viral arthritis. Acta Reumatologica Portuguesa. 2020;45(4):278&#x2013;280.</Citation><ArticleIdList><ArticleId IdType="pubmed">33420769</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladds E, Rushforth A, Wieringa S, et al. Persistent symptoms after Covid-19: qualitative study of 114 &#x201c;long Covid&#x201d; patients and draft quality principles for services. BMC Health Serv Res. 2020;20(1). doi:10.1186/s12913-020-06001-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-020-06001-y</ArticleId><ArticleId IdType="pmc">PMC7750006</ArticleId><ArticleId IdType="pubmed">33342437</ArticleId></ArticleIdList></Reference><Reference><Citation>Sykes DL, Holdsworth L, Jawad N, Gunasekera P, Morice AH, Crooks MG. Post-COVID-19 symptom burden: what is long-COVID and how should we manage it? Lung. 2021;199(2):113&#x2013;119. doi:10.1007/s00408-021-00423-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00408-021-00423-z</ArticleId><ArticleId IdType="pmc">PMC7875681</ArticleId><ArticleId IdType="pubmed">33569660</ArticleId></ArticleIdList></Reference><Reference><Citation>Strickland JC, Stoops WW. The use of crowdsourcing in addiction science research: amazon mechanical Turk. Exp Clin Psychopharmacol. 2019;27(1):1&#x2013;18. doi:10.1037/pha0000235</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/pha0000235</ArticleId><ArticleId IdType="pubmed">30489114</ArticleId></ArticleIdList></Reference><Reference><Citation>Cunningham JA, Godinho A, Kushnir V. Using Mechanical Turk to recruit participants for internet intervention research: experience from recruitment for four trials targeting hazardous alcohol consumption. BMC Med Res Methodol. 2017;17(1):156. doi:10.1186/s12874-017-0440-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12874-017-0440-3</ArticleId><ArticleId IdType="pmc">PMC5709932</ArticleId><ArticleId IdType="pubmed">29191161</ArticleId></ArticleIdList></Reference><Reference><Citation>McConnell S, Kolopack P, Davis AM. The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC): a review of its utility and measurement properties. Arthritis Care Res. 2001;45(5):453&#x2013;461. doi:10.1002/1529-0131(200110)45:5&lt;453::AID-ART365&gt;3.0.CO;2-W</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1529-0131(200110)45:5&lt;453::AID-ART365&gt;3.0.CO;2-W</ArticleId><ArticleId IdType="pubmed">11642645</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Schulz KF, Altman DG The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Ann Intern Med. 2001;134:657&#x2013;662.. doi:10.7326/0003-4819-134-8-200104170-00011</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-134-8-200104170-00011</ArticleId><ArticleId IdType="pubmed">11304106</ArticleId></ArticleIdList></Reference><Reference><Citation>Glasgow RE, Huebschmann AG, Brownson RC. Expanding the CONSORT figure: increasing transparency in reporting on external validity. Am J Prev Med. 2018;55(3):422&#x2013;430. doi:10.1016/j.amepre.2018.04.044</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amepre.2018.04.044</ArticleId><ArticleId IdType="pubmed">30033029</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021;11(1). doi:10.1038/s41598-021-95565-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Pal A, Roongta R, Mondal S, et al. Does post-COVID reactive arthritis exist? Experience of a tertiary care centre with a review of the literature. Reumatolog&#xed;a Cl&#xed;nica. 2022. doi:10.1016/j.reuma.2022.03.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.reuma.2022.03.004</ArticleId><ArticleId IdType="pmc">PMC9096625</ArticleId><ArticleId IdType="pubmed">35578636</ArticleId></ArticleIdList></Reference><Reference><Citation>Kocyigit BF, Akyol A. Reactive arthritis after COVID-19: a case-based review. Rheumatol Int. 2021;41(11):2031&#x2013;2039. doi:10.1007/s00296-021-04998-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-021-04998-x</ArticleId><ArticleId IdType="pmc">PMC8456072</ArticleId><ArticleId IdType="pubmed">34550429</ArticleId></ArticleIdList></Reference><Reference><Citation>Gracia-Ramos A, Martin-Nares E, Hernandez-Molina G. New onset of autoimmune diseases following COVID-19 diagnosis. Cells. 2021;10(12):3592. doi:10.3390/cells10123592</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10123592</ArticleId><ArticleId IdType="pmc">PMC8700122</ArticleId><ArticleId IdType="pubmed">34944099</ArticleId></ArticleIdList></Reference><Reference><Citation>Vojdani A, Vojdani E, Kharrazian D, Ascherman DP, Richmond JM. Reaction of human monoclonal antibodies to SARS-CoV-2 proteins with tissue antigens: implications for autoimmune diseases. Front Immunol. 2021;11:1. doi:10.3389/fimmu.2020.617089</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.617089</ArticleId><ArticleId IdType="pmc">PMC7873987</ArticleId><ArticleId IdType="pubmed">33584709</ArticleId></ArticleIdList></Reference><Reference><Citation>Padiyar S, Kamath N, Mathew J, et al. New-onset Adult-onset Still&#x2019;s disease-like syndrome after ChAdOx1 nCoV-19 vaccination-a case series with review of literature. Clin Rheumatol. 2022;1:3. doi:10.1007/s10067-022-06065-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-022-06065-7</ArticleId><ArticleId IdType="pmc">PMC8764317</ArticleId><ArticleId IdType="pubmed">35041110</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-Gonz&#xe1;lez MDC, Peral-Garrido ML, Calabuig I, et al. Case series of acute arthritis during COVID-19 admission. Ann Rheum Dis. 2021;80(4):e58&#x2013;e58. doi:10.1136/annrheumdis-2020-217914</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-217914</ArticleId><ArticleId IdType="pubmed">32471899</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Kutzbach A, Chac&#xf3;n-S&#xfa;chite J, Garc&#xed;a-Ferrer H, Iraheta I. Reactive arthritis: update 2018. Clin Rheumatol. 2018;37(4):869&#x2013;874. doi:10.1007/s10067-018-4022-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-018-4022-5</ArticleId><ArticleId IdType="pubmed">29455267</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>